BRIDGEWATER, N.J., Nov. 17, 2016 /PRNewswire/ -- A new survey reveals that 90% of men in the U.S. want to take charge of their own health. The U.S. is one of eight countries that participated in this survey of 16,000 adults in an effort to better understand the state of men's health around the world. Its results were unveiled today in anticipation of International Men's Day, which is coming up this Saturday, November 19.
In addition to this strong motivation to take charge of their health, the survey found that men in the U.S. are confident about their ability to do so. Specifically, the U.S. portion of the survey found:
- Men are more confident about their ability to manage their health (89%) than they are about making career decisions (73%).
- Specific areas of their health that men want to work on include improving their level of fitness (85%), reducing their fatigue/boosting their energy levels (83%) and improving their diet/nutrition (84%).
- Despite the common misconception that men avoid seeing a doctor, most men (94%) are proactive about seeing their doctor. Many men (84%) also say they talk to their pharmacist, including when they have a question about a prescription medication or an over-the-counter (OTC) product.
- When a health issue arises, most men say they have enough knowledge to identify it (87%) and figure out what to do about it (90%).
The survey also found that sexual health is an important priority for men in the U.S. – and that "sexual health" means much more to them than just sex itself. Key findings on this topic from the U.S. portion of the survey include the following:
- Nearly 1 in 3 men (30%) say sexual health is one of the most important elements of their overall health and wellness – and this doesn't solely apply to younger men. The number of men ages 55+ who say sexual health is one of the most important elements of their overall health and wellness is the same as that of men ages 18-25 (30%).
- Men believe sexual health is a multifaceted mix of both physical and emotional factors, including the ability to perform sexual intercourse (84%), a regular frequency of intercourse (75%), the ability to achieve sexual satisfaction (84%), being free of genital diseases or infections (92%), and a sense of emotional intimacy with their partner (83%).
- Most men (74%) say having a healthy sexual relationship is critical to their happiness.
"The results of this survey are promising, as they suggest that men are more proactive than ever when it comes to their health and wellness," said Ana Fadich, Vice President of Men's Health Network. "They also reaffirm something we have heard first-hand from men across the country, which is that sexual health is a critical aspect of both their health and happiness. It will be important for us to keep this in mind as we continue our efforts to empower men to live healthier lives."
The U.S. portion of this survey was conducted online by Harris Poll on behalf of Chattem, Inc., the U.S. consumer healthcare division of Sanofi, in partnership with the Men's Health Network, a non-profit organization that advocates for men's health from August 31 to September 6, 2016 among 2,031 U.S adult men and women aged 18 or older, including 832 men. Data are weighted where necessary by gender, age, race/ethnicity, region, education, and income. Visit MensHealthNetwork.org for more information.
Chattem, Inc. is the U.S. consumer healthcare division of Sanofi. Founded in 1879 as the Chattanooga Medicine Company, Chattem is now one of the leading manufacturers and marketers of branded consumer healthcare products in the United States. With more than 30 well-known brands, including ACT® Fluoride Mouth Rinse, Allegra®, Cortizone-10®, Gold Bond®, Icy Hot®, Nasacort® Allergy 24HR and Rolaids®, Chattem's products are medicine cabinet staples in millions of homes.
For more information, please visit www.chattem.com
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Sanofi is the holding company of a consolidated group of subsidiaries and operates in the United States as Sanofi US. For more information on Sanofi US, please visit http://www.sanofi.us and http://www.news.sanofi.us/social-media or call 1-800-981-2491.
About Men's Health Network
The Men's Health Network is an international non-profit organization with the mission to educate and advocate for men's health. The organization provides awareness messages, learning material, screening programs and advocacy opportunities to reach men and boys where they work, live, pray and play.
Sanofi Forward-Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects", "anticipates", "believes", "intends", "estimates", "plans" and similar expressions. Although Sanofi's management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the absence of guarantee that the product candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives, Sanofi's ability to benefit from external growth opportunities and/or obtain regulatory clearances, risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic conditions, the impact of cost containment initiatives and subsequent changes thereto, the average number of shares outstanding as well as those discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in Sanofi's annual report on Form 20-F for the year ended December 31, 2015. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.
Tel. : 908-981-3164